Symptomatic destructive spondyloarthropathy secondary to β2-microglobulin amyloidosis. Report of four cases

References

• Kleinman K S, Coburn J W. Amyloid syndrome associated with hemodialysis. Kidney Int 1989; 35: 567–575
   PubMed Web of Science ®Google Scholar
• Stone W J, Hakim R M. Beta-2-microglobulin amyloidosis in long-term dialysis patients. Am J Nephrol 1989; 9: 177–183
   PubMed Web of Science ®Google Scholar
• Mufioz-Gomez J, Gomez-Perez R, Sole-Arques M. Clinical picture of the amyloid arthropathy in patients with chronic renal failure maintained on haemodialysis using cellulose membranes. Ann Rheumat Dis 1987; 46: 573–579
   PubMed Web of Science ®Google Scholar
• Charra B, Calemard E, Uzan M, Terrat J C, Vanel T, Laurent G. Carpal tunnel syndrome, shoulde pain and amyloid deposits in long-term hemodialysis patients. Proc Eur Dial Transplant Assoc 1984; 21: 291–295
   Google Scholar
• Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitomo T, Katoaka H, Suzuki M, Hirasawa Y, Shirahama T, Cohen A S, Schmid K. A new form of amyloid protein associated with chronic hemodialysis was identified as Beta-2-microglobulin. Biochem Biophys Res Commun 1985; 129: 701–706
   PubMed Web of Science ®Google Scholar
• Shirahama T, Skinner M, Cohen A S, Gejyo F, Arakawa M, Suzuki M, Hirasawa Y. Histochemical and immu-nohistochemical characterization of amyloid associated with chronic hemodialysis as beta-2- microglobulin. Lab Invest 1985; 53: 705–709
   PubMed Web of Science ®Google Scholar
• Gorevic P D, Casey T T, Stone W J, DiRaimondo C R, Prelli F C, Frangione B. Beta-2-microglobulin is an amyloidogenic protein in man. J Clin Invest 1985; 76: 2425–2429
   PubMed Web of Science ®Google Scholar
• Morita T, Suzuki M, Kamimura A, Hirasawa Y. Amyloidosis of a possible new type in patients receiving long-term hemodialysis. Arch Pathol Lab Med 1985; 109: 1029–1032
   PubMed Web of Science ®Google Scholar
• Bardin T, Zingraff J, Shrihama T, Noel L H, Voisin M C, Driieke T, Skinner M, Cohen A S, Kuntz D. He- modialysis-associated amyloidosis and Beta-2-microglobulin. Clinical and immunohistochemical study. Am J Med 1987; 83: 419–424
   PubMed Web of Science ®Google Scholar
• Casey T T, Stone W J, Di Raimondo C R, Brantley B D, Di Raimondo C HV, Gorevic P D, Page D L. Tumoral amyloidosis of bone of beta 2-microglobulin origin in association with long-term hemodialysis: a new type of amyloid disease. Human Pathol 1986; 17: 731–738
   PubMed Web of Science ®Google Scholar
• Bardin T, Kuntz D, Zingraff J, Voisin M C, Zelmar A, Lansaman J. Synovial amyloidosis in patients undergoing long-term hemodialysis. Arthritis Rheumat 1985; 28: 1052–1058
   PubMed Web of Science ®Google Scholar
• Maury C PJ. Beta-2-microglobulin amyloidosis. A systemic amyloid disease affecting primarily synovium and bone in long-term dialysis patients. Rheumatol Int 1990; 10: 1–8
   PubMed Web of Science ®Google Scholar
• Campistol J M, Solé M, Muñoz-Gomez J, Lopez-Pedret J, Revert L. Systemic involvement of dialysis-amyloi-dosis. Am J Nephrol 1990; 10: 389–396
   PubMed Web of Science ®Google Scholar
• Nöel L H, Zingraff J, Bardin T, Atienza C, Kuntz D, Drüeke T. Tissue distribution of dialysis amyloidosis. Clin Nephrol 1987; 27: 175–178
   PubMed Web of Science ®Google Scholar
• Solé M, Cardesa A, Palacin A, Muñoz-Gomez J, Campistol J M. Morphological and immunohistochemical findings in dialysis- related amyloidosis. Appl Pathol 1989; 7: 350–360
   PubMedGoogle Scholar
• Kuntz D, Naveau B, Bardin T, Drüeke T, Treves R, Dryll A. Destructive spondiloarthopathies in hemodialyzed patients. A new syndrome?. Arthritis Rheum 1984; 27: 369–375
   PubMedGoogle Scholar
• Sebert J L, Fardellone P, Marie A, Deramond H, Lambrey G, Legars D, Galibert P, Smajda A, Fournier A. Destructive spondyloarthroptahy in hemodialyzed patients: role of amyloidosis. Arthritis Rheum 1986; 29: 301–303
   PubMedGoogle Scholar
• Rafto S, Dalinka M K, Schebler M L, Burk D L, Kricun M E. Spondyloarthropathy of the cervical spine in long-term hemodialysis. Radiology 1984; 166: 201–204
   Google Scholar
• Bindi P, Chanard J. Destructive spondyloarthropathy in dialysis patients: an overview. Nephron 1990; 55: 104–109
   PubMed Web of Science ®Google Scholar
• Naito M, Ogata K, Nakamoto M, Goya T, Sugioka Y. Destructive spondyloarthropathy during long-term hemodialysis. J Bone Joint Surg (Br) 1990; 74-B: 686–690
   Google Scholar
• Allain T J, Stevens P E, Bridges L R, Phillips M E. Dialysis myeloptahy: quadriparesis due to extradural amyloid of β2-microglobulin origin. Br Med J 1988; 296: 752–753
   PubMedGoogle Scholar
• Danesh T R, Klinkmann J, Yokoo H, Ivanovich P. Fatal cervical spondyloarthropathy in a hemodialysis patient with systemic deposition of β2-microglobulin amyloid. Am J Kidney Dis 1999; 33: 563–566
   PubMed Web of Science ®Google Scholar
• Ohashi K, Hara M, Kawai R, Ogura Y, Honda K, Nihei H, Kimura N. Cervical discs are most susceptible to beta-2-microglobulin amyloid deposition in the vertebral column. Kidney Int 1992; 41: 1646–1652
   PubMed Web of Science ®Google Scholar
• Bindi P, Lavaud S, Bernieh B, Toupance O, Chanard J. Early and late occurrences of destructive spondyloarthropathy in hemodialysis patients. Nephrol Dial Transplant 1990; 5: 199–203
   PubMed Web of Science ®Google Scholar
• Miyata T, Inagi R, Lida Y, Sato M, Yamada N, Oda O, Maeda K, Seo H. Involvement of β2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-a and interleukin-I. J Clin Invest 1994; 93: 521–528
   PubMed Web of Science ®Google Scholar
• Sakata S, Takahashi M, Kushida K, Oikawa M, Hoshino H, Denda M, Inoue T. The relationship between pentosidine and hemodialysis-related connective tissue disorders. Nephron 1998; 78: 260–265
   PubMed Web of Science ®Google Scholar
• Muñoz-Gomez J, Estrada P. Early radiologic manifestations of destructive spondyloar-thropathy in hemodialyzed patients. Arthritis Rheum 1987; 28: 1075–1076
   Google Scholar
• Kerr R, Bjorkengren A, Bielecki D K, Resnick D, Feinstein E I. Destructive spondyloarthropathy in hemodiaylisis patients. Skeletal Radiol 1988; 17: 176–180
   PubMed Web of Science ®Google Scholar
• Rousselin B, Helenon O, Zingraff J, Delons S, Drueke T, Bardin T, Moreau J F. Pseudotumor of the craniocervical junction during long-term hemodialysis. Arthritis Rheum 1990; 33: 1561–1513
   Google Scholar
• Maruyama H, Geyjo F, Arakawa M. A magnetic resonance imaging study of destructive spondyloarthropathy in long-term hemodialysis patients. Nephron 1991; 59: 71–74
   PubMed Web of Science ®Google Scholar
• van Ypersele C, Jadoul M, Malgem J, Maldague B, Jamart J. Effect of dialysis membrane and patient's age on signs of dialysis related amyloidosis. Kidney lnt 1991; 39: 1012–1019, and the working party on dialysis amyloidosis
   PubMed Web of Science ®Google Scholar
• Jadoul M, Malghem J, Pirson Y, Maldague B, Ypersele C. Effect of renal transplantation on the radiological signs of dialysis amyloid osteoarthropathy. Clin Nephrol 1989; 32: 194–197
   PubMed Web of Science ®Google Scholar
• Campistol J M, Munoz-Gomez J, Oppenheimer F, Ricart M J, Vilardell J, Andreu J. Renal transplantation for dialysis arthropathy. Lancet 1988; ii: 900
   Google Scholar